Melinda Lackey
Equibles does not estimate personal net worth.
About Melinda Lackey
Alaunos Therapeutics, Inc. reported in an 8-K filed July 22, 2025 that Melinda Lackey resigned as Legal and Administrative Officer, effective August 15, 2025. Alaunos Therapeutics, Inc. reported in an 8-K filed November 15, 2023 that Melinda Lackey was terminated as Senior Vice President, Legal and Administration, effective November 15, 2023. The proxy statement of Alaunos Therapeutics, Inc. reports total compensation of $430,370 for Melinda Lackey in fiscal 2024. Disclosed compensation is on record for 3 fiscal years.
“Concurrent with this notice, Ms. Lackey is resigning as Legal and Administrative Officer and as the Company's corporate secretary as of the Effective Date.”
“on November 10, 2023, Alaunos Therapeutics, Inc. (the "Company") terminated the employment of Melinda Lackey, Senior Vice President, Legal and Administration, and Drew Deniger, Vice President, Research and Development, "Without Cause" (as defined in their respective employment agreements) and, per their respective retention agreements, not because either failed to perform their duties at an "Acceptable Level" (as defined therein), effective November 15, 2023.”
Affiliation history
-
Alaunos Therapeutics, Inc. (TCRT)
Proxy statement
Start not stated–2025-08-15
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Alaunos Therapeutics, Inc. (TCRT) | Legal & Administration, Corporate Secretary | — | $430,370 |
| 2023 | Alaunos Therapeutics, Inc. (TCRT) | SVP, Legal & Administration | $312,084 | $701,737 |
| 2022 | Alaunos Therapeutics, Inc. (TCRT) | SVP, Legal & Administration | $325,000 | $764,743 |